LR1143
LR1143 is a dopamine transporter (DAT) and 5-HT uptake inhibitor, with IC50 values of 3.4 nM and 112 nM in rats, respectively. LR1143 binds to DAT labeled with the dopamine reuptake inhibitor GBR 12935 (HY-12242A), with an IC50 of 4.4 nM. LR1143 shows lower selectivity for DAT than for serotonin reuptake sites. LR1143 can be used in studies related to cocaine abuse.
For research use only. We do not sell to patients.
- CAS No.: 150151-15-8
- Formula: C29H34F2N2O
- Molecular Weight:464.59
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
LR1143 exhibits high affinity for rat striatal DAT (IC50=4.4 nM) and inhibits [3H]DA reuptake in rat caudate nucleus (IC50=3.4 nM), with 33-fold selectivity for DA reuptake sites over 5HT reuptake sites (IC50=112 nM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:rat striatal
-
Concentration:IC50 assay
-
Incubation Time:18-24 h (DAT binding), 15 min ([3H]DA reuptake), 30 min ([3H]5HT reuptake)
-
Result:Exhibited high affinity for rat striatal DAT with an IC50 of 4.4 nM, inhibits [3H]DA reuptake in the rat caudate nucleus with an IC50 of 3.4 nM, and demonstrates 33-fold selectivity for DA reuptake sites over 5HT reuptake sites, which have an IC50 of 112 nM.
Chemical Information
-
CAS No. 150151-15-8
-
Molecular Weight 464.59
-
Formula C29H34F2N2O
-
SMILES
FC1=CC=C(C=C1)C(OCCN2CCN(CCC2)CCCC3=CC=CC=C3)C4=CC=C(C=C4)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Matecka D, et al. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909). J Med Chem. 1996;39(24):4704-4716. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
LR1143 Related Classifications
HY-124186 Related Classifications
Powered by Bioz